Pharmacokinetic and pharmacodynamic exploration of various combinations of tegoprazan immediate and delayed-release formulations.

Park, Sooyoun; Yang, Eunsol; Kim, Byungwook; Kwon, Jihoon; Jang, In-Jin; Lee, Seung Hwan

Park, Sooyoun; Yang, Eunsol; Kim, Byungwook; Kwon, Jihoon; Jang, In-Jin; Lee, Seung Hwan.

Afiliación

Park S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Yang E; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Kim B; Kidney Research Institute, Seoul National University Medical Research Center, Seoul, Republic of Korea.
Kwon J; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Jang IJ; Statistics Team, APACE, Seoul, Republic of Korea.
Lee SH; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.

Br J Clin Pharmacol ; 89(9): 2877-2887, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37170677

Palabras clave

clinical pharmacology; crossover study; intragastric pH monitoring; phase 1 study; potassium-competitive acid blocker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google